Abstract:Objective To systematically review the correlation between CYP3A5 genotypes and blood levels of tacrolimus(FK506) in renal transplant recipients.Methods Such databases as PubMed(January 1966 to July 2013),Sciverse(January 1823 to July 2013),he Cochrane Library(Issue 7,2013),CNKI(January 1994 to July 2013),VIP(January 1989 to July 2013),CBM(January 1978 to July 2013) and WanFang Data(January 1995 to July 2013) were electronically searched for studies about the correlation between CYP3A5 genotypes and FK506(blood concentration/dose-respones relationship) in renal transplant recipients.According to the inclusion and exclusion criteria,literature was screened,data were extracted,and the methodological quality of included studies was also assessed.hen,meta-analysis was performed using RevMan 5.2 sotware.Results A total of 12 articles involving 956 patients were included.he results of meta-analysis showed that,ater renal transplantation,there was a high dose-adjusted concentration of CYP3A5 *3/*3 carriers on the 7thday(MD=54.61,95%CI –67.67 to –41.54,P<0.000 01),in the 1stmonth(MD=–74.84,95%CI –83.39 to –66.29,P<0.000 01),in the 3rdmonth(MD=–96.09,95%CI –107.55 to –84.64,P<0.000 01),in the 6thmonth(MD=–107.30,95%CI –125.65 to –88.95,P<0.000 01),and in the 1styear(MD=–78.32,95%CI –123.02 to –33.61,P=0.000 6).he dose-adjusted concentration of FK506 in CYP3A5 *3/*3 patients was higher than the other genotypes,while the doseadjusted concentration of FK506 in CYP3A5 *1/*1 patients was low.Conclusion he blood concentration as well as dose-respones relationship of FK506 are associated with CYP3A5 genotype in renal transplant recipients.We propose that patients with renal transplantation should receive CYP3A5 genotypes test to determine the use of FK506 as an immunosuppressant,so as to guide its clinical application.

Associations of VDR polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients

Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients

Association Of Cyp3a4*18b Polymorphisms With The Pharmacokinetics Of Tacrolimus In Chinese Renal Transplant Recipients

Influence of CYP 3A5*3 genetic polymorphism on tacrolimus pharmacokinetics in renal transplant recipients

Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients

Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients

The Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.

Effect of CYP3A5 genetic polymorphism on blood drug concentration and efficacy of tacrolimus in Chinese renal transplant recipients

Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy

Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients

Associations of CYP3A4/5 and POR Polymorphisms with Tacrolimus Concentrations in Chinese Adult Heart Transplant Recipients

CYP 3A 5 and MDR1 Gene Polymorphisms is Associated with Pharmacokinetic Variation of Tacrolimus in Renal Transplant Patients

Association of Hemoglobin Levels, CYP3A5, and NR1I3 Gene Polymorphisms with Tacrolimus Pharmacokinetics in Liver Transplant Patients

Effect of cytochrome P450 3A5 (CYP3A5) genotype on tacrolimus dose requirement in renal transplant patients

IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients

Effect of CYP3A4 and CYP3A5 Gene Polymorphisms on Tacrolimus Plasma Concentration in Renal Transplanted Recipients in the Han Population

Influence Of Cyp3a5 And Mdr1 Polymorphisms On Tacrolimus Concentration In The Early Stage After Renal Transplantation

Effect of CYP3A5 and MDR1 Gene Polymorphism on Concentration/Dose Ratios of Tacrolimus in Chinese Liver Transplant Patients

[Associations of SUMO4 Polymorphisms with Tacrolimus Concentrations in Chinese Renal Transplant Recipients].

Correlation between CYP3A5 Genotypes and Blood Levels of Tacrolimus in Renal Transplant Recipients: A Systematic Review